- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03900000
Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's Disease (PaKogOH)
June 30, 2023 updated by: Andrea Maier, RWTH Aachen University
Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's Disease: Does a Successful Treatment of Orthostatic Hypotension Measurably Enhance Attention and Memory Functions in Parkinson's Disease
Study on orthostatic Hypotension in Parkinson's disease
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Orthostatic hypotension (OH) in Parkinson's disease (PD) may not only be related to dizziness or light headedness but to deficits in attention, visual, and verbal memory.
Would a successful treatment of OH which includes physiotherapy significantly improve OH and these cognitive deficits?
By means of a randomized cross-over trial, we want to measure and compare the effects of OH therapy on orthostatic tolerance, as well as on attention, visuo-spatial working memory, and verbal memory in patients with PD.
If confirmed, therapy of orthostatic hypotension would provide a sound and simple approach to improve those cognitive deficits originating from orthostatic hypotension.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
NRW
-
Aachen, NRW, Germany, 52074
- University Hospital, RWTH Aachen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Parkinson's patients
- Diagnostis of OH
- able to perform an ambulatory physiotherapy at Aachen University Hospital.
Exclusion Criteria:
- deep brain stimulation or Pacemaker
- severe psychiatric disease
- severe heart disease
- severe vascular encephalopathy
- dementia
- pregnant or lactating women
- extreme pain or immobility
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Short_Physiotherapy
one period of physiotherapy (8 weeks)
|
Ambulatory leg-muscle oriented physiotherapy (2 x 45 minutes per week for at least 8 weeks) at Aachen University Hospital.
Daily protocol of leg muscle training, exercises, sufficient fluid intake of 2liter/day, pressure stockings.
|
|
Other: Long_Physiotherapy
two periods of physiotherapy (à 8 weeks)
|
Ambulatory leg-muscle oriented physiotherapy (2 x 45 minutes per week for at least 8 weeks) at Aachen University Hospital.
Daily protocol of leg muscle training, exercises, sufficient fluid intake of 2liter/day, pressure stockings.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Pressure in mmHg
Time Frame: 10months
|
Systolic postural blood pressure drop in the interventional Group (Long_Physiotherapy) less than 10mmHg (5-15mmHg) compared to Short_Physiotherapy
|
10months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attention in TAP
Time Frame: 10months
|
Attention Tasks (TAP) ≥ 20% Change in Long_Physiotherapy
|
10months
|
|
Orthostatic symptoms (Winkler Scale)
Time Frame: 10months
|
≥ 2 points change in Winkler Scale (Sum Score) in Long_Physiotherapy; 10 symptoms must be rated concerning their frequency from 0= never to 4= more than once a day.
Sum score from minimum 0 points (no symptoms) to maximum 40 points (all symptoms more than once daily) is interpreted
|
10months
|
|
daytime sleepiness
Time Frame: 10months
|
Epworth Sleepiness Scale ≥ 20% Change of Sum Score in Long_Physiotherapy.
Sum Score can range from minimum = 0 Points to Maximum = 24points.
More points indicate more symptoms.
Cut off for daytime sleepiness are10 points
|
10months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andrea Maier, Dr. med., Universitiy hospital RWTH Aachen, Department of Neurology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2014
Primary Completion (Actual)
October 31, 2018
Study Completion (Actual)
October 31, 2018
Study Registration Dates
First Submitted
December 28, 2018
First Submitted That Met QC Criteria
April 1, 2019
First Posted (Actual)
April 2, 2019
Study Record Updates
Last Update Posted (Actual)
July 5, 2023
Last Update Submitted That Met QC Criteria
June 30, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Parkinsonian Disorders
- Basal Ganglia Diseases
- Movement Disorders
- Synucleinopathies
- Neurodegenerative Diseases
- Autonomic Nervous System Diseases
- Primary Dysautonomias
- Orthostatic Intolerance
- Parkinson Disease
- Hypotension
- Hypotension, Orthostatic
- Pure Autonomic Failure
Other Study ID Numbers
- 13-131
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.